Our Life Sciences R&D cloud platform enables experiments to be rapidly automated51-200 Employees
- Growth StageExpanding market presence
Synthace Funding
$0
55 rounds
Synthace is active in the following markets / industries: biotechnology, life sciences, SaaS, pharmaceuticals, synthetic biology, bioinformatics, artificial intelligence, industrial automation, software, internet of things and hardware + software. The company has secured funding across 5 rounds and is valued at $0. Their most recent funding was raised on December 12, 2018.
Funding Rounds
B
$25600000Series BDec 2018
A
$9600000S
$3500000
S
$2000000
S
$900000
Investors of Synthace
Rounds
B
We run the startup development programs HAX, IndieBio, Chinaccelerator, MOX, and dlab
Rounds
B
S
White Cloud Capital
Rounds
A
Amadeus Capital Partners
Rounds
A
11.2 Capital
Rounds
A
Midven
David Lucas
30 plus years of sales experience, customer service experience, wholesale, retail and business to business
Investor & Entrepreneur.
Founder, Top Tier Impact.
Rainbow Seed Fund
Rounds
S